Hand–foot syndrome in sorafenib and lenvatinib treatment for advanced thyroid cancer

Objective: The aim of this study was to assess the clinical impact of hand–foot syndrome (HFS) during treatment with two multikinase inhibitors, sorafenib and lenvatinib, in a large group of patients with advanced thyroid cancer. Moreover, we looked for possible associations between HFS occurrence a...

Полное описание

Библиографические подробности

Главные авторы:	Elisa Minaldi, Virginia Cappagli, Loredana Lorusso, Laura Valerio, Carlotta Giani, Matilde Viglione, Laura Agate, Eleonora Molinaro, Antonio Matrone, Rossella Elisei
Формат:	Artigo
Язык:	Inglês
Опубликовано:	Bioscientifica 2024-08-01
Серии:	European Thyroid Journal
Предметы:	hand–foot syndrome lenvatinib sorafenib thyroid cancer tyrosine kinase inhibitors
Online-ссылка:	https://etj.bioscientifica.com/view/journals/etj/13/4/ETJ-24-0009.xml
Метки:	Добавить метку Нет меток, Требуется 1-ая метка записи!